Correlation Between Aslan Pharmaceuticals and Erasca
Can any of the company-specific risk be diversified away by investing in both Aslan Pharmaceuticals and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aslan Pharmaceuticals and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aslan Pharmaceuticals and Erasca Inc, you can compare the effects of market volatilities on Aslan Pharmaceuticals and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aslan Pharmaceuticals with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aslan Pharmaceuticals and Erasca.
Diversification Opportunities for Aslan Pharmaceuticals and Erasca
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Aslan and Erasca is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Aslan Pharmaceuticals and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Aslan Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aslan Pharmaceuticals are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Aslan Pharmaceuticals i.e., Aslan Pharmaceuticals and Erasca go up and down completely randomly.
Pair Corralation between Aslan Pharmaceuticals and Erasca
If you would invest 259.00 in Erasca Inc on September 1, 2024 and sell it today you would earn a total of 27.00 from holding Erasca Inc or generate 10.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Aslan Pharmaceuticals vs. Erasca Inc
Performance |
| Timeline |
| Aslan Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Erasca Inc |
Aslan Pharmaceuticals and Erasca Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aslan Pharmaceuticals and Erasca
The main advantage of trading using opposite Aslan Pharmaceuticals and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aslan Pharmaceuticals position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.| Aslan Pharmaceuticals vs. Monte Rosa Therapeutics | Aslan Pharmaceuticals vs. NewAmsterdam Pharma | Aslan Pharmaceuticals vs. Inventiva Sa | Aslan Pharmaceuticals vs. Cullinan Oncology LLC |
| Erasca vs. Century Therapeutics | Erasca vs. Keros Therapeutics | Erasca vs. Monte Rosa Therapeutics | Erasca vs. Design Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |